Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)320-321
Number of pages2
JournalJournal of Clinical Pathology
Volume68
Issue number4
DOIs
Publication statusPublished - 1 Jan 2015

Cite this